Josep Bassaganya-Riera
Directeur Général chez Biotherapeutics, Inc.
Postes actifs de Josep Bassaganya-Riera
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Biotherapeutics, Inc.
 Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Directeur Général | - | - |
| Président | - | - | |
| Fondateur | 01/01/2008 | - | |
| President | - | - | |
| Nutritional Immunology & Molecular Medicine Laboratory | Directeur/Membre du Conseil | 01/07/2002 | - |
| Directeur Général | 01/07/2002 | - | |
| Fondateur | 01/07/2002 | - | |
| President | 01/07/2002 | - |
Historique de carrière de Josep Bassaganya-Riera
Anciens postes connus de Josep Bassaganya-Riera
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LANDOS BIOPHARMA, INC. | Directeur Général | 01/01/2017 | 06/11/2021 |
| Président | 01/01/2017 | 06/11/2021 | |
| Fondateur | 01/01/2017 | 06/11/2021 | |
| President | 01/01/2017 | 06/11/2021 | |
| Virginia Polytechnic Institute & State University | Corporate Officer/Principal | - | - |
Formation de Josep Bassaganya-Riera
| Universitat Autònoma de Barcelona | Undergraduate Degree |
| Iowa State University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Espagne | 2 |
Opérationnelle
| Chief Executive Officer | 3 |
| Founder | 3 |
| President | 3 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LANDOS BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Health Technology |
| Nutritional Immunology & Molecular Medicine Laboratory |
- Bourse
- Insiders
- Josep Bassaganya-Riera
- Expérience
